520 related articles for article (PubMed ID: 11145695)
1. The role of IL-10 in promoting disease progression in leishmaniasis.
Kane MM; Mosser DM
J Immunol; 2001 Jan; 166(2):1141-7. PubMed ID: 11145695
[TBL] [Abstract][Full Text] [Related]
2. The relative contribution of IL-4 receptor signaling and IL-10 to susceptibility to Leishmania major.
Noben-Trauth N; Lira R; Nagase H; Paul WE; Sacks DL
J Immunol; 2003 May; 170(10):5152-8. PubMed ID: 12734362
[TBL] [Abstract][Full Text] [Related]
3. Skin-derived macrophages from Leishmania major-susceptible mice exhibit interleukin-12- and interferon-gamma-independent nitric oxide production and parasite killing after treatment with immunostimulatory DNA.
von Stebut E; Belkaid Y; Nguyen B; Wilson M; Sacks DL; Udey MC
J Invest Dermatol; 2002 Sep; 119(3):621-8. PubMed ID: 12230504
[TBL] [Abstract][Full Text] [Related]
4. Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.
Padigel UM; Farrell JP
J Immunol; 2005 May; 174(10):6340-5. PubMed ID: 15879134
[TBL] [Abstract][Full Text] [Related]
5. Nonhealing infection despite Th1 polarization produced by a strain of Leishmania major in C57BL/6 mice.
Anderson CF; Mendez S; Sacks DL
J Immunol; 2005 Mar; 174(5):2934-41. PubMed ID: 15728505
[TBL] [Abstract][Full Text] [Related]
6. Mice lacking the TNF receptor p55 fail to resolve lesions caused by infection with Leishmania major, but control parasite replication.
Vieira LQ; Goldschmidt M; Nashleanas M; Pfeffer K; Mak T; Scott P
J Immunol; 1996 Jul; 157(2):827-35. PubMed ID: 8752935
[TBL] [Abstract][Full Text] [Related]
7. Analysis of cytokine production by inflammatory mouse macrophages at the single-cell level: selective impairment of IL-12 induction in Leishmania-infected cells.
Belkaid Y; Butcher B; Sacks DL
Eur J Immunol; 1998 Apr; 28(4):1389-400. PubMed ID: 9565379
[TBL] [Abstract][Full Text] [Related]
8. Leishmania promastigotes evade interleukin 12 (IL-12) induction by macrophages and stimulate a broad range of cytokines from CD4+ T cells during initiation of infection.
Reiner SL; Zheng S; Wang ZE; Stowring L; Locksley RM
J Exp Med; 1994 Feb; 179(2):447-56. PubMed ID: 7905017
[TBL] [Abstract][Full Text] [Related]
9. Phagocytosis of Leishmania mexicana amastigotes by macrophages leads to a sustained suppression of IL-12 production.
Weinheber N; Wolfram M; Harbecke D; Aebischer T
Eur J Immunol; 1998 Aug; 28(8):2467-77. PubMed ID: 9710224
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility or resistance to Leishmania infection is dictated by the macrophages evolved under the influence of IL-3 or GM-CSF.
Saha B; Saini A; Germond R; Perrin PJ; Harlan DM; Davis TA
Eur J Immunol; 1999 Jul; 29(7):2319-29. PubMed ID: 10427995
[TBL] [Abstract][Full Text] [Related]
11. Leishmania major amastigotes initiate the L-arginine-dependent killing mechanism in IFN-gamma-stimulated macrophages by induction of tumor necrosis factor-alpha.
Green SJ; Crawford RM; Hockmeyer JT; Meltzer MS; Nacy CA
J Immunol; 1990 Dec; 145(12):4290-7. PubMed ID: 2124240
[TBL] [Abstract][Full Text] [Related]
12. Absence of Tumor Necrosis Factor Supports Alternative Activation of Macrophages in the Liver after Infection with
Hu S; Marshall C; Darby J; Wei W; Lyons AB; Körner H
Front Immunol; 2018; 9():1. PubMed ID: 29403488
[TBL] [Abstract][Full Text] [Related]
13. Enhanced replication of Leishmania amazonensis amastigotes in gamma interferon-stimulated murine macrophages: implications for the pathogenesis of cutaneous leishmaniasis.
Qi H; Ji J; Wanasen N; Soong L
Infect Immun; 2004 Feb; 72(2):988-95. PubMed ID: 14742545
[TBL] [Abstract][Full Text] [Related]
14. Leishmania major inhibits IL-12 in macrophages by signalling through CR3 (CD11b/CD18) and down-regulation of ETS-mediated transcription.
Ricardo-Carter C; Favila M; Polando RE; Cotton RN; Bogard Horner K; Condon D; Ballhorn W; Whitcomb JP; Yadav M; Geister RL; Schorey JS; McDowell MA
Parasite Immunol; 2013 Dec; 35(12):409-20. PubMed ID: 23834512
[TBL] [Abstract][Full Text] [Related]
15. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response.
Mattner F; Magram J; Ferrante J; Launois P; Di Padova K; Behin R; Gately MK; Louis JA; Alber G
Eur J Immunol; 1996 Jul; 26(7):1553-9. PubMed ID: 8766560
[TBL] [Abstract][Full Text] [Related]
16. IL-4-independent inhibition of IL-12 responsiveness during Leishmania amazonensis infection.
Jones DE; Buxbaum LU; Scott P
J Immunol; 2000 Jul; 165(1):364-72. PubMed ID: 10861073
[TBL] [Abstract][Full Text] [Related]
17. Regulation of macrophage IL-12 synthesis by Leishmania phosphoglycans.
Piedrafita D; Proudfoot L; Nikolaev AV; Xu D; Sands W; Feng GJ; Thomas E; Brewer J; Ferguson MA; Alexander J; Liew FY
Eur J Immunol; 1999 Jan; 29(1):235-44. PubMed ID: 9933105
[TBL] [Abstract][Full Text] [Related]
18. The role of mannose receptor during experimental leishmaniasis.
Akilov OE; Kasuboski RE; Carter CR; McDowell MA
J Leukoc Biol; 2007 May; 81(5):1188-96. PubMed ID: 17261547
[TBL] [Abstract][Full Text] [Related]
19. IL-9 is a susceptibility factor in Leishmania major infection by promoting detrimental Th2/type 2 responses.
Arendse B; Van Snick J; Brombacher F
J Immunol; 2005 Feb; 174(4):2205-11. PubMed ID: 15699153
[TBL] [Abstract][Full Text] [Related]
20. Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice.
Carrera L; Gazzinelli RT; Badolato R; Hieny S; Muller W; Kuhn R; Sacks DL
J Exp Med; 1996 Feb; 183(2):515-26. PubMed ID: 8627163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
